APA (7th ed.) Citation

CM, M., IJ, K., MJ, J., WJ, O., A, S., & CP, B. (2021). Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.., 65(1), 51. https://doi.org/10.23736/S1824-4785.19.03129-7

Chicago Style (17th ed.) Citation

CM, Mulders-Manders, Kouijzer IJ, Janssen MJ, Oyen WJ, Simon A, and Bleeker-Rovers CP. "Optimal Use of [18F]FDG-PET/CT in Patients with Fever or Inflammation of Unknown Origin." The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. 65, no. 1 (2021): 51. https://doi.org/10.23736/S1824-4785.19.03129-7.

MLA (9th ed.) Citation

CM, Mulders-Manders, et al. "Optimal Use of [18F]FDG-PET/CT in Patients with Fever or Inflammation of Unknown Origin." The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.., vol. 65, no. 1, 2021, p. 51, https://doi.org/10.23736/S1824-4785.19.03129-7.